Most-Favored-Nation Drug Pricing Agreements Expanded to Nine Additional Pharmaceutical Manufacturers
The expansion of MFN pricing could have downstream consequences for acquisition costs, reimbursement methodologies, manufacturer contracting, patient access and pharmacy economics. On August 31, 2026, ...
This is a significant development for companies facing pixel- and tracking-technology class actions, but it is not a complete solution to CIPA tracking litigation. California has passed Senate Bill ...
NEW JERSEY, September 2, 2026—Duane Morris LLP is pleased to announce that the firm has been recognized in two categories of the 2026 New Jersey Legal Awards. The annual awards celebrate the attorneys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results